The Neuro joins neuroscience data sharing partnership
Canadian Open Neuroscience Platform will make disseminating and publishing data easier
Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer鈥檚 disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.
To improve access to critical data, and to continue its policy of being a leader in open science, The Montreal Neurological Institute and Hospital (The Neuro) of 不良研究所 has joined (CONP), a new data sharing partnership that will break down the barriers to collaboration, facilitating the distribution of data across the Canadian neuroscience community and beyond.
The partnership was inaugurated today when Health Canada and Brain Canada announced a $10M grant, awarded through the Canada Brain Research Fund, to establish CONP. The grant was announced by David Lametti, Member of Parliament for LaSalle-脡mard-Verdun and Parliamentary Secretary to the Minister of Innovation, Science and Economic Development, in the presence of Suzanne Fortier, Principal and Vice-Chancellor of 不良研究所, Dr. Guy Rouleau, Director of The Neuro, and Inez Jabalpurwala, President and CEO of Brain Canada.
The most valuable findings often come from aggregating multiple forms of data, for example genetic, behavioural, and brain imaging data. Through CONP, leading neuroscientists across Canada will pool data from diverse sources, maximizing the potential for breakthroughs that improve the lives of people with neurological disease. CONP will consolidate many forms of data within a federated national platform, joining several institutional databases to increase ease of access and re-use.
As well as sharing existing data, CONP will help researchers store, analyze, and disseminate new data. They will have access to 8,000-10,000 terabytes of storage space from Compute Canada, and CONP will provide a network for inter-disciplinary training.
To encourage successful drug development, CONP will share early-stage findings among academic and pharmaceutical partners through the Tanenbaum Open Science Institute at The Neuro. This will save researchers valuable time and resources by preventing the duplication of failed trials. Partners will also be encouraged to publish their findings openly rather than in pay-walled journals, to maximize the impact of their work.
鈥淐ONP will fill a void that exists right now in Canadian neuroscience research,鈥� says Alan Evans, CONP鈥檚 Scientific Director, and a researcher at The Neuro. 鈥淲e have massive amounts of data across many disciplines but there are too many barriers to accessibility and collaboration. CONP will break down these barriers.鈥�
CONP is made up of researchers from the University of British Columbia, Simon Fraser University, University of Calgary, University of Alberta, Western University, Brock University, University of Toronto, York University, Queen鈥檚 University, Concordia University, 不良研究所, Universit茅 de Montreal, Universit茅 de Sherbrooke, Universit茅 Laval, and Dalhousie University.
About The Montreal Neurological Institute and Hospital
The Montreal Neurological Institute and Hospital 鈥� The Neuro 鈥� is a world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical centre in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world鈥檚 top minds makes The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders. In 2016, The Neuro became the first institute in the world to fully embrace the Open Science philosophy, creating the Tanenbaum Open Science Institute. The Montreal Neurological Institute is a 不良研究所 research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the 不良研究所 Health Centre.
听
听
